百度(09888.HK)成立獨立芯片公司崑崙芯 估值130億人幣
內媒《36氪》報道,百度(09888.HK)旗下人工智能晶片部門「崑崙」近日成立獨立芯片公司崑崙芯(北京)科技,由百度芯片首席架構師歐陽劍擔任CEO。
今年3月,有市場消息指百度崑崙已完成20億美元獨立融資,引入CPE源峰、IDG資本、君聯資本、元禾璞華等投資者,預期投後估值增至約130億元人民幣。
報道指,第一代崑崙芯片於2020年初量產,目前已經規模化部署超過2萬片,第二代崑崙芯片亦已經流片成功,計劃於年下半年量產,料AI性能較第一代提升3倍以上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.